Updated survival analysis of a randomized phase III study of subcutaneous versus intravenous bortezomib in patients with relapsed multiple myeloma (Q36936514)
Jump to navigation
Jump to search
scientific article published on 11 June 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Updated survival analysis of a randomized phase III study of subcutaneous versus intravenous bortezomib in patients with relapsed multiple myeloma |
scientific article published on 11 June 2012 |
Statements
1 reference
Updated survival analysis of a randomized phase III study of subcutaneous versus intravenous bortezomib in patients with relapsed multiple myeloma (English)
1 reference
Philippe Moreau
1 reference
Sebastian Grosicki
1 reference
Bertrand Arnulf
1 reference
Halyna Pylypenko
1 reference
Ievgenii Karamanesht
1 reference
Helgi van de Velde
1 reference
Huaibao Feng
1 reference
Andrew Cakana
1 reference
William Deraedt
1 reference
1 reference
Identifiers
1 reference